Hoth Therapeutics 2022 Clinical-Stage Biopharmaceutical Investor Presentation

Hoth Therapeutics is a NASDAQ-listed clinical-stage biopharmaceutical company developing next-generation therapeutics targeting rare diseases and unmet patient needs. The company focuses on early-stage drug development programs that address significant treatment gaps while minimizing side effects for chronic and rare disease patients.